Liquidia Corp (LQDA)
13.29
-0.52
(-3.77%)
USD |
NASDAQ |
Apr 19, 16:00
13.29
0.00 (0.00%)
After-Hours: 16:25
Liquidia Cash from Investing (TTM): -11.29M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -11.29M |
September 30, 2023 | -11.57M |
June 30, 2023 | -1.192M |
March 31, 2023 | -0.951M |
December 31, 2022 | -0.587M |
September 30, 2022 | -0.116M |
June 30, 2022 | -0.022M |
March 31, 2022 | -0.055M |
December 31, 2021 | -0.107M |
September 30, 2021 | 0.874M |
June 30, 2021 | 0.7515M |
March 31, 2021 | 0.3781M |
December 31, 2020 | 0.2479M |
Date | Value |
---|---|
September 30, 2020 | -0.847M |
June 30, 2020 | -1.360M |
March 31, 2020 | -1.787M |
December 31, 2019 | -1.850M |
September 30, 2019 | -1.817M |
June 30, 2019 | -1.321M |
March 31, 2019 | -0.8592M |
December 31, 2018 | -0.8709M |
September 30, 2018 | -2.064M |
June 30, 2018 | -2.963M |
March 31, 2018 | -2.750M |
December 31, 2017 | -2.544M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-11.57M
Minimum
Sep 2023
0.874M
Maximum
Sep 2021
-1.717M
Average
-0.847M
Median
Sep 2020
Cash from Investing (TTM) Benchmarks
United Therapeutics Corp | -719.60M |
Abbott Laboratories | -3.133B |
AIM ImmunoTech Inc | -0.832M |
Protalix BioTherapeutics Inc | -16.71M |
Armata Pharmaceuticals Inc | -8.134M |